• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Volcano’s Q3 profits plunge 50 percent

Volcano’s Q3 profits plunge 50 percent

November 1, 2011 By MassDevice staff

Volcano Corp.

Volcano Corp. (NSDQ:VOLC) are down 4.4 percent this morning after the medical device company reported its third-quarter numbers yesterday, beating Wall Street’s expectations despite plunging profits, but lowering the top end of its sales guidance for the rest of the year.

The San Diego-based medical device maker posted profits of $2.6 million, or 5 cents per share, on sales of $85.8 million for the three months ended Sept. 30.

That’s a 17.7 percent increase to the top line, but a 52.9 percent hit to the bottom line, compared with profits of $5.6 million, or 10 cents per share, on sales of $72.9 million.

Meet Volcano CEO Scott Huennekens at the MassDevice Big 100 West

Analysts had expected EPS of 4 cents, but Volcano still disappointed The Street with its forecast for 2011 revenues. The company said it now expects to log sales of $342 million to $345 million for the full year, down from a top end of $347 million, citing "current expectations for healthcare procedure activity and telecom business sales." Earnings are pegged at 19 cents to 21 cents (under analysts’ forecast of 22 cents).

Sign up to get our free newsletters delivered right to your inbox

“Given the increased focus on comparative effectiveness, we continue to be optimistic about the long-term prospects for our current and future offerings – particularly IVUS – as recent data from the Matrix study reinforces positive outcomes with respect to reduction in deaths and adverse events when using IVUS versus the use of angiography alone,” president & CEO Scott Huennekens said in prepared remarks. "Over the next year, we will be introducing enhancements to our current offerings, as well as new products that will enable us to address new markets."

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Q3, Volcano Corp.

More recent news

  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy